Prospective isolation of mouse and human hematopoietic stem cells using PLXDC2.

Area of Science:

• Hematology
• Stem Cell Biology
• Immunology

Background:

• Hematopoietic stem cells (HSCs) are crucial for blood formation and immune system function.
• Current HSC isolation methods rely on complex marker combinations and flow cytometry, with limited success using imaging techniques.
• Developing reliable markers for HSC identification is essential for research and clinical applications.

Purpose of the Study:

• To identify novel molecular markers for accurate identification of both mouse and human hematopoietic stem cells (HSCs).
• To evaluate the utility of PLXDC2 as a potential marker for HSCs in preclinical and clinical settings.

Main Methods:

• Generation of a green fluorescent protein (GFP) knock-in mouse model (Plxdc2-GFP) to track Plxdc2 expression.
• Flow cytometry analysis of Plxdc2-GFP expression in mouse HSCs.
• Development of a novel antibody for human PLXDC2 detection.
• Xenograft transplantation assays using human cord blood HSCs to assess long-term reconstitution potential.

Main Results:

• Plxdc2-GFP was highly expressed in mouse HSCs, with a significant proportion of Plxdc2-GFP+CD150+ cells demonstrating long-term multi-lineage reconstitution potential.
• Human PLXDC2+ HSCs exhibited superior long-term multilineage reconstitution ability compared to PLXDC2- HSCs in xenograft models.
• PLXDC2 was validated as a useful marker for identifying both mouse and human cord blood HSCs.

Conclusions:

• PLXDC2 is a highly relevant and effective marker for the identification of hematopoietic stem cells (HSCs) in both mice and humans.
• The findings suggest PLXDC2 can improve the accuracy of HSC isolation and characterization.
• This study opens new avenues for HSC research and potential therapeutic strategies.